Today: 13 June 2026
Bank of America stock ends 2025 down as Fed liquidity signal sets up Jan. 14 earnings test
1 January 2026
2 mins read

Bank of America stock ends 2025 down as Fed liquidity signal sets up Jan. 14 earnings test

NEW YORK, January 1, 2026, 11:58 ET — Market closed

  • BAC ended Dec. 31 at $55.00, down 0.5%, in the final U.S. session of 2025.
  • Year-end trading put Treasury yields and money-market liquidity back in focus.
  • Investors are looking to Bank of America’s Jan. 14 results for guidance on margins and credit.

Bank of America Corp (BAC.N) shares closed at $55.00 on Wednesday, down 0.51%, in the last U.S. session of 2025. U.S. stocks are closed on Thursday for the New Year’s Day holiday.

The pause leaves investors heading into bank earnings season with few fresh company catalysts and a sharp focus on rates. Bank of America has set Jan. 14 for its fourth-quarter results.

For big lenders, the key question is whether funding costs keep easing as the Fed cuts rates, or whether deposit pricing stays sticky. Net interest income — the gap between what a bank earns on loans and pays on deposits — often swings on that spread.

Wall Street ended 2025 on a soft note in thin trade, with the S&P 500 down 0.74% and the Dow off 0.63% on Wednesday, Reuters reported. The U.S. 10-year yield rose 3.5 basis points to 4.163%.

Other major bank stocks also drifted lower into the holiday close, with JPMorgan Chase and Citigroup slightly down and Wells Fargo weaker, according to market data.

Treasury yields firmed after weekly jobless claims fell to a seasonally adjusted 199,000 for the week ended Dec. 27, below economists’ expectations, Reuters reported. The report fed a steady “no hire, no fire” view of the labor market heading into early-January data. Reuters

Funding markets also drew attention after financial firms tapped the Federal Reserve’s standing repo facility for $74.6 billion on Dec. 31, a record daily total for the backstop, a Reuters analysis showed. “Given the soft funding … appears the funding market is more secure, there’s less panic,” said Scott Skyrm, executive vice president at Curvature Securities. Reuters

The standing repo facility is a Fed backstop that lets eligible institutions swap Treasury collateral for overnight cash, helping keep short-term rates from spiking at quarter-end. For banks, tighter money markets can seep into wholesale funding costs and, eventually, margins.

Before the next session on Friday, Jan. 2, traders will be watching whether year-end positioning unwinds in financials as liquidity returns. Bank stocks have tended to track moves in the yield curve, with longer-term yields guiding expectations for lending spreads.

On the data calendar, the Institute for Supply Management’s manufacturing PMI report for December is due at 10 a.m. ET on Monday, Jan. 5, ISM said. The U.S. jobs report for December is scheduled for Friday, Jan. 9, and the CPI report for December on Tuesday, Jan. 13, according to the Labor Department’s release schedule.

Fed-watchers will also parse incoming data after minutes from the central bank’s December meeting highlighted divisions over the outlook, Reuters reported. The Fed’s next policy meeting is Jan. 27-28, with investors expecting no change in rates, Reuters said.

Technically, BAC has a near-term pivot around $55, with Wednesday’s intraday high at $55.42 and low at $54.93, according to Investing.com data. A break below that low would open room toward the mid-$54 area; a push back above $55.42 would put the $56 level back in view.

Until earnings season delivers new guidance, Bank of America shares are likely to take their cue from rates, funding conditions and the first wave of January macro data. Investors will be looking for signs that loan growth and credit quality can hold up even as deposit pricing adjusts to a lower-rate environment.

Stock Market Today

  • Telix Pharmaceuticals Phase 3 ProstACT Safety Data Boosts Investment Outlook
    June 12, 2026, 8:05 PM EDT. Telix Pharmaceuticals (ASX:TLX) announced early Phase 3 ProstACT trial data for TLX591-Tx in metastatic castration-resistant prostate cancer, demonstrating an acceptable safety and tolerability profile with no new safety concerns. The lower kidney and salivary gland exposure compared to existing therapies could signal a differentiated advantage. This supports Telix's shift from diagnostics to higher-value therapeutics but hinges on upcoming pivotal trial results. A new U.S. collaboration with United Imaging aims to enhance theranostics workflow and commercial scale. Despite promising clinical progress, risks include regulatory scrutiny following an SEC subpoena over prostate cancer disclosures. Analysts forecast 22.7% annual revenue growth to A$1.2 billion by 2029, with an 85% upside to Telix's current price. Market watchers weigh potential regulatory and execution challenges against long-term growth prospects in theranostics.

Latest articles

SGH Limited Holds Back as ASX 200 Pushes Higher Before FY26 Results

SGH Limited Holds Back as ASX 200 Pushes Higher Before FY26 Results

13 June 2026
SGH closed at A$41.51, up 0.70% but underperformed the S&P/ASX 200’s 1.98% surge, as investors weighed solid cash flow and Boral margin gains against a high 36.03 P/E, mixed demand, and M&A risk; the next key catalyst is FY26 results on August 11, with analysts’ average target at A$47.64, 14.76% above Friday’s close.
NCR Voyix Rallies 10% After Investors Shift on Turnaround Bets

NCR Voyix Rallies 10% After Investors Shift on Turnaround Bets

13 June 2026
NCR Voyix soared 10.25% to $7.85, far outpacing the market, as investors focus on the company’s 2026 cash-flow and earnings targets; the next key catalyst is the Q2 2026 earnings update, with stock valuation appearing low if management delivers on margin and cash-flow goals, but risks remain with declining reported revenue and high debt.
Apple stock slips into 2026 as year-end tech pullback bites; AAPL earnings next
Previous Story

Apple stock slips into 2026 as year-end tech pullback bites; AAPL earnings next

EV Stocks Today: BYD’s weakest growth in five years and Tesla deliveries set up Friday’s trade
Next Story

EV Stocks Today: BYD’s weakest growth in five years and Tesla deliveries set up Friday’s trade

Go toTop